These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 13816747)

  • 1. [Therapy of pulmonary tuberculosis with pyrazinamide].
    van DIJK B; KRAAN JK
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1960; 122():71-5. PubMed ID: 13816747
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical indications and evaluations on the treatment of pulmonary tuberculosis with pyrazinamide. II. Association of pyrazinamide with isoniazid or other antimycobacterial agents and to cortisonic drugs].
    PASTEGA G
    G Ital Tuberc Mal Torace; 1961; 15():280-311. PubMed ID: 14484246
    [No Abstract]   [Full Text] [Related]  

  • 3. [Kidney function in patients with pulmonary tuberculosis during treatment with antitubercular agents, with special reference to pyrazinamide].
    Spychalski W; Grzegorzewska A; Westfal I
    Pneumonol Pol; 1987 Oct; 55(10):454-7. PubMed ID: 3438179
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison between morphazinamide and pyrazinamide in retreatment of pulmonary tuberculosis].
    Zierski M
    Minerva Med; 1965 Sep; 56(71):2953-4. PubMed ID: 5322283
    [No Abstract]   [Full Text] [Related]  

  • 5. [The antitubercular activity of a pyrazinamide derivative: morphazinamide].
    Grassi C
    Acta Tuberc Pneumol Belg; 1966; 57(3):196-210. PubMed ID: 4862621
    [No Abstract]   [Full Text] [Related]  

  • 6. [Short-term treatment of tuberculosis with and without pyrazinamide in the second phase (TA-80)].
    Farga V; Valenzuela P; Yañez A; Valenzuela MT; Scheel G; Mendoza F; Torres E; Icekson I; Grinspun M; Fernández M
    Rev Med Chil; 1983 Jul; 111(7):750-4. PubMed ID: 6680460
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparison of the effect of morphazinamide and pyrazinamide in the treatment of chronic tuberculosis].
    Zierski M
    Gruzlica; 1965 Sep; 33(9):769-71. PubMed ID: 5859903
    [No Abstract]   [Full Text] [Related]  

  • 8. Treating pyrazinamide mono-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Pérez-Arellano CP; García-Toledo D
    Int J Tuberc Lung Dis; 2013 Sep; 17(9):1244-5. PubMed ID: 23928174
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of Mycobacterium tuberculosis' sensitivity to pyrazinamide on a BACTEC-960 bacteriological analyzer].
    Irtuganova OA; Smirnova NS; Slogotskaia LV
    Probl Tuberk Bolezn Legk; 2003; (7):40-2. PubMed ID: 12939878
    [No Abstract]   [Full Text] [Related]  

  • 10. SEQUENTIAL use of paired combinations of isoniazid, streptomycin, para-aminosalicylic acid, and pyrazinamide. A United States Public Health Service tuberculosis therapy trial.
    Am Rev Respir Dis; 1959 Nov; 80():627-40. PubMed ID: 13856609
    [No Abstract]   [Full Text] [Related]  

  • 11. Pyrazinamide deamidase activity in tuberculous disease.
    Gurumurthy P; Krishnamurthy PV; Garhupati Sarma G
    Am Rev Respir Dis; 1981 Jul; 124(1):97. PubMed ID: 7020509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The present state of short course chemotherapy including pyrazinamide in Japan].
    Yamagishi F
    Nihon Kokyuki Gakkai Zasshi; 2004 Jun; 42(6):481-5. PubMed ID: 15228133
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sensitivity of M. tuberculosis to pyrazinamide (author's transl)].
    Pivet HT; Barrios J
    Rev Med Chil; 1981 Mar; 109(3):208-11. PubMed ID: 6792678
    [No Abstract]   [Full Text] [Related]  

  • 14. [CHEMO-ANTIBIOTIC THERAPY IN PULMONARY TUBERCULOSIS].
    RUSSO V
    Rass Int Clin Ter; 1963 Sep; 43():1009-13. PubMed ID: 14091636
    [No Abstract]   [Full Text] [Related]  

  • 15. [Metabolism of morphazinamide in patients with pulmonary tuberculosis].
    Zierski M
    Minerva Med; 1965 Sep; 56(70):2759-62. PubMed ID: 5852634
    [No Abstract]   [Full Text] [Related]  

  • 16. [Short-term chemotherapy of tuberculosis with 5-month regimens with and without pyrazinamide in the 2d phase (TA-82)].
    Farga V; Valenzuela P; Valenzuela MT; Schell G; Lagos A; Nuñez A; Soto R; Fernández M; Corradini ; Araya D
    Rev Med Chil; 1986 Jul; 114(7):701-5. PubMed ID: 3299595
    [No Abstract]   [Full Text] [Related]  

  • 17. MORPHAZINAMIDE (PIAZOLINA) IN TREATMENT OF PULMONARY TUBERCULOSIS. (PRELIMINARY REPORT).
    ZIERSKI M
    G Ital Chemioter; 1963; 10():171-9. PubMed ID: 14085319
    [No Abstract]   [Full Text] [Related]  

  • 18. [EVALUATION OF THERAPEUTIC RESULTS IN CHRONIC CAVITARY TUBERCULOSIS TREATED WITH ETHIONAMIDE, CYCLOSERINE AND PYRAZINAMIDE. (A JOINT STUDY ON RESULTS AND PROSPECTS)].
    FORTIC B; KOMAR M
    Tuberkuloza; 1964; 16():359-71. PubMed ID: 14306418
    [No Abstract]   [Full Text] [Related]  

  • 19. [RESULTS OBTAINED BY THE USE OF PYRAZINAMIDE AND MORPHAZINAMIDE IN AEROSOL ADMINISTRATION IN PNEUMOLOGY].
    KALLOS Z
    G Ital Chemioter; 1963; 10():180-9. PubMed ID: 14079400
    [No Abstract]   [Full Text] [Related]  

  • 20. [EXPERIENCES AND RESULT WITH SECONDARY DRUGS (ETHIONAMIDE, D-CYCLOSERINE, PYRAZINAMIDE AND VIOCIN) IN SURGICAL TREATMENT OF PULMONARY TUBERCULOSIS].
    VOIGT H; WILLROTH P
    Z Tuberk Erkr Thoraxorg; 1964 Oct; 122():398-403. PubMed ID: 14325221
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.